Outlook for screening for sphingolipidoses.
Winchester
B
B
Biochemistry, Endocrinology, and Metabolism Unit, Institute of Child Health, London, UK.
D015703:Antigens, CD; D001896:Boron Compounds; D002478:Cells, Cultured; D005347:Fibroblasts / Q000378:metabolism / Q000473:pathology; D005456:Fluorescent Dyes; D006801:Humans; D007790:Lactosylceramides; D008247:Lysosomes / Q000378:metabolism / Q000473:pathology; D008403:Mass Screening; D008856:Microscopy, Fluorescence; D012680:Sensitivity and Specificity; D013106:Sphingolipidoses / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology
C095489:4,4-difluoro-4-bora-3a,4a-diaza-s-indacene; D015703:Antigens, CD; D001896:Boron Compounds; D005456:Fluorescent Dyes; D007790:Lactosylceramides; C009744:CDw17 antigen